In conclusion, we have developed Hu5F9-G4, a humanized blocking anti-CD47 antibody that exerts anti-leukemic effects both in vitro and in vivo leading to the eradication of AML in xenotransplant mouse models and a major survival benefit. The gene discussed is CD47; the disease is acute myeloid leukemia.